tradingkey.logo
tradingkey.logo
Search

Healthcare Services & Equipment

LIST1013
1166.448USD
+23.562+2.06%
Close 06/26, 16:00ETQuotes delayed by 15 min
2.73TMarket Cap
1.17BVolume
Key Figures
1142.886Open
1167.118High
1.17BVolume
230Up
67Down
43Unchanged
2.73TMarket Cap
1142.886Prev. Close
1142.886Low
30.96BTurnover

Healthcare Services & Equipment

1166.448
+23.562+2.06%

Related Stocks

No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
Invo Fertility Ord Shs
Invo Fertility Ord Shs
IVF
2.450
+1.210
+97.58%
4.80
115.63M
163.21M
2.21M
1.64M
104.83
76.75
210.000
1.380
0.00
0.00
+63.33%
+64.43%
+44.12%
-9.93%
+172.22%
-88.88%
+225.54%
Ryojbaba Ord Shs
Ryojbaba Ord Shs
RYOJ
2.690
+0.605
+29.02%
--
9.99M
20.61M
24.08M
11.55M
93.52
112.49
11.430
1.560
0.00
0.00
+11.16%
+1.51%
-32.75%
+17.47%
+0.75%
--
-11.80%
Nano-X Imaging Ltd
Nano-X Imaging Ltd
NNOX
1.090
+0.211
+23.95%
6.45
28.48M
25.39M
75.86M
69.59M
55.69
5.57
5.720
1.590
0.00
0.00
-34.73%
-36.26%
-44.39%
-51.98%
-61.48%
-79.16%
-61.07%
4
Modular Medical Inc
Modular Medical Inc
MODD
4.940
+0.820
+19.90%
5.18
889.48K
2.92M
26.73M
2.04M
42.94
6.77
30.000
3.134
0.00
0.00
-4.08%
+0.82%
-3.89%
-6.44%
+1183.45%
+627.65%
+1256.77%
5
Kestra Medical Technologies Ltd
Kestra Medical Technologies Ltd
KMTS
26.430
+3.850
+17.05%
8.17
1.57M
36.44M
1.54B
58.35M
19.57
5.05
30.000
13.250
0.00
0.00
+32.61%
+31.23%
+24.38%
+32.61%
+8.36%
+49.58%
-0.34%
6
Biodesix Inc
Biodesix Inc
BDSX
23.340
+3.300
+16.47%
7.26
154.54K
2.82M
241.70M
8.25M
12.92
1.22
20.210
5.000
0.00
0.00
+38.85%
+57.70%
+45.97%
+60.97%
+261.30%
+366.24%
+243.24%
7
Helius Medical Technologies Inc
Helius Medical Technologies Inc
HSDT
1.730
+0.240
+16.11%
5.36
444.02K
550.42K
101.01M
43.74M
20.80
1.06
204.755
1.590
0.00
0.00
+6.79%
+14.57%
-15.20%
+0.00%
-44.01%
-83.60%
-40.14%
8
PAVmed Inc
PAVmed Inc
PAVM
5.050
+0.700
+16.09%
6.85
36.65K
130.27K
36.15M
30.93K
17.01
0.74
28.440
6.000
0.00
0.00
-2.13%
+3.27%
-19.46%
-50.25%
-31.11%
+741.67%
-23.76%
9
Quanterix Corp
Quanterix Corp
QTRX
4.320
+0.560
+14.89%
7.10
3.60M
12.66M
203.50M
47.06M
17.42
2.18
8.770
3.360
0.00
0.00
+27.43%
+42.57%
+41.64%
+22.73%
-32.81%
-35.04%
-32.08%
10
Lumexa Imaging Holdings Ord Shs
Lumexa Imaging Holdings Ord Shs
LMRI
12.100
+1.520
+14.37%
5.16
2.11M
21.00M
1.02B
96.11M
15.40
3.55
19.450
6.450
0.00
0.00
+28.59%
+27.10%
+57.14%
+40.70%
-31.05%
--
-34.59%

News

TradingKey The Week on Wall Street: Ceasefire Hopes, AI Boom Lift US Stocks to New Highs; Inflation and Policy Risks Remain

TradingKey - US markets were closed on Monday, May 25, for Memorial Day. Geopolitical optimism surrounding US-Iran diplomatic talks continued to influence markets, with hopes for a ceasefire or deal regarding the Strait of Hormuz. Kevin Warsh, who was sworn in as Federal Reserve Chair on Friday, May

TradingKeyMon, Jun 1
TradingKey - US markets were closed on Monday, May 25, for Memorial Day. Geopolitical optimism surrounding US-Iran diplomatic talks continued to influence markets, with hopes for a ceasefire or deal regarding the Strait of Hormuz. Kevin Warsh, who was sworn in as Federal Reserve Chair on Friday, May

Eli Lilly Zepbound Returns to CVS Formulary, Pre-Market Shares Rise as Much as 2%

TradingKey - Eli Lilly (LLY) shares rose nearly 2% in Thursday’s pre-market session as the market focused on a major decision from U.S. healthcare giant CVS Health (CVS). CVS announced it would restore insurance coverage for the weight-loss drug Zepbound and include Foundayo, an oral weight-loss medication newly approved in April, in its standard drug formulary.

TradingKeyThu, May 28
TradingKey - Eli Lilly (LLY) shares rose nearly 2% in Thursday’s pre-market session as the market focused on a major decision from U.S. healthcare giant CVS Health (CVS). CVS announced it would restore insurance coverage for the weight-loss drug Zepbound and include Foundayo, an oral weight-loss medication newly approved in April, in its standard drug formulary.

PPI Report April 2026: How Inflation Data Is Moving HIMS, CEG, and PLUG Stock Today

TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

TradingKeyWed, May 13
TradingKey - Wall Street is navigating a two-day inflation gauntlet. Tuesday's CPI print for April arrived hotter than expected, rattling equity markets from telehealth to nuclear energy. Wednesday morning brings the Producer Price Index (PPI) for April — and if today's Consumer Price Index is any g

Hims & Hers (HIMS) Q1 2026 Earnings Preview: GLP-1 Pivot, Subscriber Surge & Stock Catalyst Watch

TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

TradingKeyTue, May 12
TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

Blue Cross Blue Shield Pays $2.67 Billion Settlement, Why ELV Stock Price Wasn’t Dragged Down?

TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

TradingKeyThu, May 7
TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

UnitedHealth Beats Q1 2026 and Raises Guidance - Is UNH Stock a Buy After Jumping 8%?

UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?

TradingKeyWed, Apr 22
UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?
KeyAI